检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:罗春丽[1] 郭永灿[1] 赵懿[1] 欧俐苹[1] 颜令[1] 朴军[2] 吴小候[2]
机构地区:[1]重庆医科大学检验系教育部重点实验室,重庆400016 [2]重庆医科大学附属第一医院泌尿外科,重庆400016
出 处:《重庆医科大学学报》2009年第10期1313-1316,共4页Journal of Chongqing Medical University
基 金:重庆市教委科学技术研究项目互助(KJ080306)
摘 要:目的:探讨shRNA干扰沉默PLCε基因对人膀胱癌T24细胞生长的影响。方法:体外构建PLCε基因的shRNA的重组质粒,Lipofectamine2000介导法转染T24细胞,采用RT-PCR方法检测特异性shRNA的重组质粒对PLCε基因沉默效果,转染后采用MTT法检测shRNA的重组质粒对细胞增殖的作用,免疫细胞化学染色法检测T24细胞PCNA的表达,电镜观察细胞超微结构的改变。结果:shRNA的重组质粒能有效下调PLCε基因的表达,抑制率为78.01%,与对照组比较其差异有统计学意义(P<0.01);细胞增殖活性受到明显抑制,与对照组比较其差异有统计学意义(P<0.01);细胞内PCNA含量明显低于空白对照组和阴性质粒组,其差异有统计学意义(P<0.01);细胞形态改变产生凋亡小体。结论:PLCε基因有望成为应用RNAi技术探索治疗膀胱癌潜在的靶基因。Objective:To investigate whether PLCε gene down regulation by RNA interference(RNAi) leads to inhibition of proliferation in human bladder carcinoma T24 cell.Methods: The shRNA recombinant plasmids targeting to PLCε gene was constructed and transfected into bladder carcinoma T24 cell with Lipofectamine 2000.RT-PCR was used to monitor the validity of specific s h R N A in down regulation of PLCε.Then MTT assay was performed for detecting cell proliferation,the changes of PCNA were analyzed by immunocytochemical method, Electron microscope was used to observe the morphological changes. Results: The specific PLC shRNA was confirmed to be efficient in silencing PLCε expression. PLCε gene down regulation by the shRNA recombinant plasmids inhibition cell proliferation rate about 78.01%, They were significantly different from that of control group (P〈0.01 ;After transfected the specific recombinant plasmids, PCNA expression was significantly decreased,They were significantly different from that of control group (P〈0.01 ;morphological changes produce apoptotic body. Conclusion: PLCε is likely to be potential molecular target for bladder carcinoma in gene therapy by RNAi.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.74